C07D311/60 - CPC Classification Index

ClassID:

95065 ⎘

C07D311/60 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Sub-classes:

C07D311/62 » with oxygen atoms directly attached in position 3 e.g. anthocyanidins 170

Recent Application in this class:

20250304545

2025-10-02

WATER-SOLUBLE HETEROCYCLYL POLYMETHINE CHROMOPHORES

20250084049

2025-03-13

POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF

20250057859

2025-02-20

CANNABICHROMENEQUINONE AND ANALOGUES THEREOF, AND METHOD OF USING COMPOSITIONS THEREOF AS ANTI-INFLAMMATORY AGENTS

20240400502

2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

20230286913

2023-09-14

INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF

20230115350

2023-04-13

TEAD INHIBITORS AND USES THEREOF

20220112159

2022-04-14

Sulfonylureas and related compounds and use of same

20220073443

2022-03-10

CANNABINOID FORMULATIONS AND METHODS OF MAKING SAME

20210121437

2021-04-29

THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF MULTIPLE MYELOMA, LYMPHOMA, AND LEUKEMIA

#10

20210053947

2021-02-25

Heterocyclic antiestrogens

#11

20210017144

2021-01-21

Method for producing solid dispersion containing nobiletin

#12

20200253918

2020-08-13

THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS

#13

20200140404

2020-05-07

Heterocyclyl polymethine IR chromophores

#14

20200054596

2020-02-20

Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers

#15

20190359564

2019-11-28

Sulfonylureas and related compounds and use of same

#16

20180370885

2018-12-27

Process for the preparation of standardized composition of arjunoglucoside from the bark of

#17

20180354936

2018-12-13

Heterocyclic antiestrogens

#18

20180230119

2018-08-16

Use of 3-deoxyanthocyanidins for treating occular diseases

#19

20180099943

2018-04-12

Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds

#20

20180098961

2018-04-12

Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers

#21

20180044287

2018-02-15

Sulfonylureas and related compounds and use of same

#22

20170360744

2017-12-21

Agent containing flavonoid derivatives for treating cancer and inflammation

#23

20170313715

2017-11-02

Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof

#24

20170305891

2017-10-26

Modulators of cystic fibrosis transmembrane conductance regulator protein

#25

20170217919

2017-08-03

Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds

#26

20170217918

2017-08-03

Antidiabetic bicyclic compounds

#27

20170166548

2017-06-15

Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

#28

20160251330

2016-09-01

Chromene derivatives as inhibitors of TCR-Nck interaction

#29

20160244424

2016-08-25

PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof

#30

20160221982

2016-08-04

Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds

#31

20160206609

2016-07-21

Neuroprotective polyphenol analogs

#32

20160090531

2016-03-31

Liquid crystal composition and liquid crystal display device

#33

20160068502

2016-03-10

Flavonoid IL-17A inhibitors

#34

20160039781

2016-02-11

Analogues of epicatechin and related polyphenols

#35

20160016928

2016-01-21

Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

#36

20150315168

2015-11-05

Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds

#37

20150299748

2015-10-22

Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same

#38

20150224484

2015-08-13

Inorganic nanoparticle deposited catalyst for hydrogenation and manufacturing method of the same, and hydrogenation for biomass derived hydrocarbon compounds

#39

20150216167

2015-08-06

SELECTIVE INHIBITION OF C4-PEP CARBOXYLASES

#40

20150210663

2015-07-30

Dihydrochalcone derivatives and their use as antibiotic agents

#41

20150065698

2015-03-05

Microwave assisted citrus waste biorefinery

#42

20140186328

2014-07-03

NEUROPROTECTIVE POLYPHENOL ANALOGS

#43

20140107095

2014-04-17

Estrogen receptor modulators and uses thereof

#44

20140045931

2014-02-13

Polyphenol proteasome inhibitors, synthesis, and methods of use

#45

20140038980

2014-02-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

#46

20140031388

2014-01-30

AKT INACTIVATION BY TOCOPHERYL DERIVATIVES

#47

20140030529

2014-01-30

CHROMENE COMPOUND

#48

20130338208

2013-12-19

Fulvene and fulvalene analogs and their use in treating cancers

#49

20130303544

2013-11-14

Benzopyrone estrogen receptor regulator

#50

20130245128

2013-09-19

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

#51

20130116232

2013-05-09

Estrogen receptor modulators and uses thereof

#52

20130090378

2013-04-11

Process for extracting compound from cranberry leaves and related products

#53

20130035382

2013-02-07

Iminochromene anti-viral compounds

#54

20120225890

2012-09-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

#55

20120135041

2012-05-31

Immunosuppressor based on the blockage of TCR-Nck interaction

#56

20120093728

2012-04-19

Mitochondrial inhibitors to treat human disease

#57

20120070664

2012-03-22

CONDENSATION PRODUCT OF RESORCIN AND ACETONE

#58

20120029067

2012-02-02

Polyphenol proteasome inhibitors, synthesis, and methods of use

#59

20110189134

2011-08-04

Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same

#60

20110172239

2011-07-14

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

#61

20110166142

2011-07-07

2-SUBSTITUTED ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USES

#62

20110144124

2011-06-16

Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies

#63

20110112146

2011-05-12

Chromene modulators of chemokine receptor activity

#64

20110082176

2011-04-07

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#65

20110015272

2011-01-20

Sirtuin 1 and the treatment of neurodegenerative diseases

#66

20100292175

2010-11-18

USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION

#67

20100179223

2010-07-15

Compounds, compositions, and methods for the treatment of synucleinopathies

#68

20100173985

2010-07-08

Polyphenol proteasome inhibitors, synthesis, and methods of use

#69

20100102274

2010-04-29

Chroman compounds

#70

20090259048

2009-10-15

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#71

20090221695

2009-09-03

Chroman derivatives as estrogenic compounds

#72

20090197965

2009-08-06

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

#73

20090143374

2009-06-04

Use of compounds and compositions for the treatment of amyloid diseases

#74

20090069432

2009-03-12

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

#75